Bausch Health Cos Common Stock Net 2010-2024 | BHC

Bausch Health Cos common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
Bausch Health Cos Annual Common Stock Net
(Millions of US $)
2023 $10,423
2022 $10,391
2021 $10,317
2020 $10,227
2019 $10,172
2018 $10,121
2017 $10,090
2016 $10,038
2015 $9,897
2014 $8,349
2013 $8,301
2012 $5,941
2011 $5,964
2010 $5,252
2009 $1,465
Bausch Health Cos Quarterly Common Stock Net
(Millions of US $)
2024-06-30 $10,483
2024-03-31 $10,480
2023-12-31 $10,423
2023-09-30 $10,420
2023-06-30 $10,412
2023-03-31 $10,405
2022-12-31 $10,391
2022-09-30 $10,387
2022-06-30 $10,380
2022-03-31 $10,373
2021-12-31 $10,317
2021-09-30 $10,312
2021-06-30 $10,300
2021-03-31 $10,289
2020-12-31 $10,227
2020-09-30 $10,219
2020-06-30 $10,217
2020-03-31 $10,209
2019-12-31 $10,172
2019-09-30 $10,168
2019-06-30 $10,165
2019-03-31 $10,151
2018-12-31 $10,121
2018-09-30 $10,117
2018-06-30 $10,114
2018-03-31 $10,103
2017-12-31 $10,090
2017-09-30 $10,086
2017-06-30 $10,085
2017-03-31 $10,041
2016-12-31 $10,038
2016-09-30 $10,034
2016-06-30 $9,915
2016-03-31 $9,906
2015-12-31 $9,897
2015-09-30 $9,900
2015-06-30 $9,881
2015-03-31 $9,810
2014-12-31 $8,349
2014-09-30 $8,334
2014-06-30 $8,326
2014-03-31 $8,316
2013-12-31 $8,301
2013-09-30 $8,260
2013-06-30 $8,250
2013-03-31 $5,943
2012-12-31 $5,941
2012-09-30 $5,917
2012-06-30 $5,885
2012-03-31 $5,937
2011-12-31 $5,964
2011-09-30 $5,981
2011-06-30 $5,873
2011-03-31 $5,199
2010-12-31 $5,252
2010-09-30 $5,190
2010-06-30 $1,468
2010-03-31 $1,467
2009-12-31 $1,465
2009-09-30 $1,464
2009-06-30 $1,464
2009-03-31 $1,464
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00